QuidelOrtho Corp·4

Feb 13, 4:20 PM ET

Strobeck Matthew 4

4 · QuidelOrtho Corp · Filed Feb 13, 2026

Research Summary

AI-generated summary of this filing

Updated

QuidelOrtho (QDEL) Director Matthew Strobeck Buys 10,000 Shares

What Happened
Matthew Strobeck, a director of QuidelOrtho Corp (QDEL), acquired 10,000 shares in open-market/private purchases on February 13, 2026. The weighted average purchase price was $23.9586 per share (range $23.7600–$23.9999), for an aggregate purchase cost of approximately $239,586. This was a buy (P) rather than a sale.

Key Details

  • Transaction date: 2026-02-13.
  • Transaction type/code: Open market or private purchase (P).
  • Price: Weighted average $23.9586; range $23.7600–$23.9999 per share.
  • Shares acquired: 10,000; total ≈ $239,586.
  • Shares owned after transaction: Not specified in the provided filing.
  • Footnotes of note:
    • F1: Reporting person will provide on request the number of shares purchased at each separate price.
    • F2: Strobeck is custodian under the Uniform Gift to Minor Act for 16,630 shares held by four of his children and disclaims beneficial ownership of those shares.
    • F3: Strobeck has sole voting and dispositive power over shares held by Birchview Fund, LLC as Managing Partner and disclaims beneficial ownership except to the extent of any pecuniary interest.
  • Timeliness: Filing and transaction are dated the same day (2026-02-13); no late filing indicated in the provided data.

Context
This was a straight open-market purchase (not an option exercise, award, or gift). Purchases by insiders are often watched by investors as one data point on insider sentiment, but the filing does not state the insider’s motivation. Note the filing includes custodial and fund-related disclosures that clarify legal control versus asserted beneficial ownership.

Insider Transaction Report

Form 4
Period: 2026-02-13
Transactions
  • Purchase

    Common Stock

    [F1]
    2026-02-13$23.96/sh+10,000$239,58627,775 total
Holdings
  • Common Stock

    [F2]
    (indirect: UGMA Account)
    16,630
  • Common Stock

    [F3]
    (indirect: Birchview)
    38,145
Footnotes (3)
  • [F1]The weighted average purchase price of these transactions was $23.9586 per share, with a range of $23.7600 to $23.9999 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
  • [F2]The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Managing Partner of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Phillip S. Askim, attorney-in-fact for Matthew W. Strobeck|2026-02-13

Documents

1 file
  • 4
    wk-form4_1771017605.xmlPrimary

    FORM 4